Treatment of Basal Cell Carcinoma: A Focus on the Role of Mohs Micrographic Surgery

Authors

  • Ciara Maguire School of Medicine, Trinity College, University of Dublin, Ireland

Keywords:

Medicine

Abstract

Basal Cell Carcinoma (BCC) is the most common cancer in human and the leading cutaneous malignancy of the fair skinned Irish population. Mohs Micrographic Surgery is a specialised operational technique used in the treatment of BCC. It involves excision of the cancer and microscopic examination of 100% of the surgical margins. It has the highest cure rate of any treatment for BCC and the best cosmetic outcome as it does not sacrifice unnecessary surrounding tissue.

Author Biography

Ciara Maguire, School of Medicine, Trinity College, University of Dublin, Ireland

Fifth Year Medicine, TCD

References

1. Anthony ML. Surgical Treatment of Nonmelanoma Skin Cancer. A.O.R.N. J. 2000;71(3):552-4,556-8,560-4
2. Dermatology. Volume 2. Bolognia, Jorizzo, Rapini. 2003
3.Rubin AI, Chen EH, Ratner D. Basal-Cell Carcinoma. N. Engl. J. Med. 2005;353(21):2262-9
4. Evidence Based Dermatology. Edited by Hywel Williams, Michael Bigby, Thomas Diepgen, Andrew Herxheimer, Luigi Naldi, Berthold Rzany. 2003. Chapter 26 p. 325 5. Pathology of the Skin with Clinical Correlations, Volume 2. McKee, Calonje, Granter. 2005. Chapter 22 p. 1169
6. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B. 2001;63:8-18
7. Cutaneous Medicine and Surgery: An integrated program in dermatology, Volume 2. Arndt, Le Boit, Robinson, Wintroub. 1996. Chapter 141 p.1387
8. Skin Disease: Diagnosis and Treatment. Habif, Campbell Jr., Chapman, Dinulos, Zug. 2005. Chapter 17 p. 424
9. Ramachandran S, Fryer AA, Lovatt TJ, Smith AG, Lear JT, Jones PW, Strange RC. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system. Cancer Letters. 2003;189 (2):175-81
10. Lear JT, Tan BB, Smith AG et al. Risk Factors for basal cell carcinoma in the UK: case-control study in 806 patients J. R. Soc. Med. 1997 Jul:90(7)371-4
11. Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC. Molecular aetiology and pathogenesis of basal cell carcinoma. Br. J. Dermatol. 2005 Jun;152(6)1108-24
12. Neville JA, Welch E, Leffell DJ. Management on nonmelanoma skin cancer in 2007. Nat. Clin. Pract. Oncol. 2007 Aug;4(8):462-9
13. Lawrence. Mohs Micrographic Surgery for Basal Cell Carcinoma. Clin. Exp. Dermatol. 1999;24(2);130-3
14. Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int. J. Dermatol. 2006 May; 45(5):489-98
15. Darmstadt GL, Steinman HK. Mohs Micrographic Surgery of the Head and Neck. West J. Med. 1990;152(2):153-8
16. Otley CC, Salasche SJ. Mohs Surgery: efficient and effective. Br. J. Ophthalmol. 2004;88(9);1228
17. Moreno-Arias GA, Izento-Menezes CM, Carrasco MA, Camps-Fresneda A. Second Intention Healing after Mohs Micrographic Surgery. J. Eur. Acad. Dermatol. Venereol. 2000 May;14(3):159-65
Review
18. Batra RS, Kelley LC. Predictors of Extensive Subclinical Spread in Nonmelanoma Skin Cancer treated with Mohs Micrographic Surgery. Arch. Dermatol. 2002;138(8):1043-51
19. Smith SB, Farley MF, Albertini JG, Elston DM. Mohs Micrographic Surgery for Granular Cell Tumor using S-100 Immunostain. Dermatol. Surg. 2002 Nov; 28(11):1076-8
20. Yaroslavsky AN, Neel V, Anderson RR. Demarcation of Nonmelanoma Skin Cancer Margins in Thick Excisions Using Multispectral Polarized Light Imaging. J. Invest. Dermatol. 2003;121(2):259-66
21. Rajadhyaksha M, Menaker G, Flotte T, Dwyer PJ, González S. Confocal examination of nonmelanoma cancers in thick skin excisions to potentially guide Mohs Micrographic Surgery without frozen histopathology. J. Invest. Dermatol. 2001;117(5):1137-43
22. Surgery of the Skin: Procedural Dermatology. Robinson, Hanke, Sengelmann, Siegel. 2005. Chapter 48
23.Textbook of Dermatologic Surgery. Ratz, Geronemus, Goldman, Malsney, Padilla. 1998 Chapter 25
24. www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Basal Cell and Squamous Cell Skin Cancers V.I.2008
25. Jonathan L. Cook, Jennifer B. Perone. A Prospective Evaluation of the Incidence of Complications Associated with Mohs Micrographic Surgery. Arch. Dermatol. 2003;139:143-52
26. Essers BAB, Dirksen CD, Neiman FHM et al. Cost-effectiveness of Mohs micrographic surgery Vs surgical excision for basal cell carcinoma of the face. Arch. Dermatol. 2006 Feb;142(2):187-94
27. Otley CC. Cost-effectiveness of Mohs micrographic surgery Vs surgical excision for basal cell carcinoma of the face. Arch. Dermatol. 2006 Sep;142(9):1235
28. Chren MM. Determining the Value of Surgical Therapies for Basal Cell Carcinoma. Arch. Dermatol. 2006 Feb;142(2):231-2

Downloads

Published

2008-01-01

How to Cite

Maguire, C. (2008). Treatment of Basal Cell Carcinoma: A Focus on the Role of Mohs Micrographic Surgery. Trinity Student Medical Journal , 9(1), Page 40–43. Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/1891

Issue

Vol. 9 No. 1 (2008): Trinity Student Medical Journal

Section

Reviews

License

Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.

Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.